Giuseppa De Luca

Genoa, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Front-line liquid biopsy for early molecular assessment and treatment of hospitalized lung cancer patients.

Front-line liquid biopsy for early molecular assessment and treatment of hospitalized lung cancer patients.

Journal: Cancer treatment and research communications

Published: February 20, 2024

The fading guardian: clinical relevance of TP53 null mutation in high-grade serous ovarian cancers.

The fading guardian: clinical relevance of TP53 null mutation in high-grade serous ovarian cancers.

Journal: Frontiers in immunology

Published: May 12, 2023

Stem-like signatures in human meningioma cells are under the control of CXCL11/CXCL12 chemokine activity.

Stem-like signatures in human meningioma cells are under the control of CXCL11/CXCL12 chemokine activity.

Journal: Neuro-oncology

Published: April 19, 2023

PD-L1 expression, BRAF and TERT mutation in a cohort of aggressive thyroid cancers: case series from a single-centre experience.

PD-L1 expression, BRAF and TERT mutation in a cohort of aggressive thyroid cancers: case series from a single-centre experience.

Journal: Journal of endocrinological investigation

Published: August 26, 2022

Targeting PIK3CA Actionable Mutations in the Circulome: A Proof of Concept in Metastatic Breast Cancer.

Targeting PIK3CA Actionable Mutations in the Circulome: A Proof of Concept in Metastatic Breast Cancer.

Journal: International journal of molecular sciences

Published: April 27, 2022

The spectrum of subclonal TP53 mutations in chronic lymphocytic leukemia: A next generation sequencing retrospective study.

The spectrum of subclonal TP53 mutations in chronic lymphocytic leukemia: A next generation sequencing retrospective study.

Journal: Hematological oncology

Published: April 05, 2022

A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients.

A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients.

Journal: Cancers

Published: March 24, 2022

The Opportunities and Challenges of Molecular Tagging Next-Generation Sequencing in Liquid Biopsy.

The Opportunities and Challenges of Molecular Tagging Next-Generation Sequencing in Liquid Biopsy.

Journal: Molecular diagnosis & therapy

Published: June 20, 2021

TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors.

TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors.

Journal: Expert opinion on investigational drugs

Published: June 20, 2020

Optimization of a WGA-Free Molecular Tagging-Based NGS Protocol for CTCs Mutational Profiling.

Optimization of a WGA-Free Molecular Tagging-Based NGS Protocol for CTCs Mutational Profiling.

Journal: International journal of molecular sciences

Published: April 24, 2020

Radiomic Detection of EGFR Mutations in NSCLC.

Radiomic Detection of EGFR Mutations in NSCLC.

Journal: Cancer research

Published: March 27, 2020

Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patients.

Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patients.

Journal: Scientific reports

Published: February 05, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026